Chemistry · Lesson
Molecular signalling, receptors and recognition
Compare equilibrium recognition, finite downstream dynamics and a separately specified amplified response to see why their concentrations and half-points differ.
Back to the Chemistry mapBy the end, you can
- Use free ligand and conserved totals in their respective binding models.
- Normalize mutually exclusive receptor-state weights.
- Follow a conserved downstream active-state pool in time.
- Separate binding K_d from the half-point of a chosen response function.
Recognition starts with a specified receptor state
A signalling molecule can bind a receptor and alter the receptor’s interactions, conformation or activity. The resulting response may involve channels, enzymes, second messengers or gene regulation. Chemical recognition and the downstream biological response are connected steps with different quantities to measure.
An affinity measured for a defined receptor state under stated conditions is not a universal constant for every cellular state. Concentrations must distinguish free ligand, receptor-bound ligand and material unavailable to that binding equilibrium.
Binding inventories and competing states use explicit free concentrations
Choose a one-state independent-site equilibrium with total receptor 2.40 nmol L⁻¹, K_d=11.0 nmol L⁻¹ and maintained free ligand 33.0 nmol L⁻¹. Occupancy θ=L_free/(K_d+L_free)=0.750, and bound receptor is 1.80 nmol L⁻¹. The corresponding local total ligand is 33.0+1.80=34.8 nmol L⁻¹, including bound ligand.
If a separate closed model instead supplies total ligand 4.10 nmol L⁻¹, solve 11x=(2.40−x)(4.10−x). The physical bound concentration is 0.581615827 nmol L⁻¹ and free ligand 3.51838417 nmol L⁻¹. Naively using total ligand as free would give 0.651655629 nmol L⁻¹ bound receptor, inconsistent with the correct equilibrium ledger.
For another maintained-reservoir model, use one mutually exclusive site with free L=7.00 nmol L⁻¹/K_d,L=7.00 and competitor C=42.0 nmol L⁻¹/K_d,C=21.0. Empty/L-bound/C-bound weights are 1/1/2. Normalizing their sum four gives fractions 0.250/0.250/0.500. Without competitor, L-bound fraction would be 0.500.
Reducing free competitor to 7.00 nmol L⁻¹ changes its weight to 1/3; empty/L-bound/C-bound fractions become 3/7, 3/7, 1/7. This operational competition does not establish a downstream response or a unique receptor conformation.
Occupancy and response have different half-points
In a simple one-state binding model, occupancy is the bound fraction of the receptor inventory. A response is a separately defined output. Amplification, spare receptor capacity, competing ligands and feedback can make a response half-point differ from a binding dissociation constant.
A ligand can bind without producing the same response as another ligand. Agonism, antagonism and other operational descriptions require the relevant response and assay context. A single saturating readout neither identifies a unique elementary mechanism nor proves clinical efficacy.
A finite downstream response and an amplified readout have their own models
For a separate symbolic state model, keep a total downstream pool 72.0 μmol L⁻¹ and denote its active concentration X; inactive concentration is 72−X. Maintain receptor occupancy θ=0.300 and assign activation parameter k_act=1.20 min⁻¹ and deactivation k_deact=0.160 min⁻¹. Define dX/dt=k_actθ(72−X)−k_deactX, with initial X=0.
The relaxation coefficient is λ=1.20×0.300+0.160=0.520 min⁻¹; steady active concentration is X_ss=72×0.360/0.520=49.8461538 μmol L⁻¹. At t=4.00 min, X=X_ss[1−exp(−λt)]=43.6188633 μmol L⁻¹ and inactive pool 28.3811367 μmol L⁻¹. The finite pool is conserved throughout.
If the model occupancy is mathematically set to zero at four minutes, subsequent activation vanishes and the active amount decays at 0.160 min⁻¹. Two minutes later X=43.6188633 exp(−0.160×2)=31.6737956 μmol L⁻¹. The response does not become instantly zero. This is an assigned state-conversion model, rather than an actual intervention or cellular kinetic fit.
For another independent one-state binding model, assign K_d=17.0 nmol L⁻¹ and θ=L_free/(17+L_free) with compatible concentration units. Define a normalized response r=(1+a)θ/(a+θ), with dimensionless coupling parameter a=0.120; r=1 at θ=1. At free L=17.0 nmol L⁻¹, occupancy is 0.500 but response r=0.903225806.
Half maximal response occurs at θ=a/(1+2a)=0.0967741935, corresponding to free ligand EC₅₀=K_d a/(1+a)=1.82142857 nmol L⁻¹. Here EC₅₀ names the half-point of this specified response function. Increasing only a to 1.20 moves it to 9.27272727 nmol L⁻¹ while the stipulated binding K_d remains 17.0. A response half-point is therefore not automatically an affinity constant.
Occupancy or normalized response
Free ligand / nmol L⁻¹
- Binding occupancy θ
- Assigned normalized response r
- — Assigned amplified response r
Underlying data
| Free ligand / nmol L⁻¹ | Occupancy or normalized response |
|---|---|
| 1.8214285714285714 | 0.0967741935483871 · Binding occupancy θ |
| 17 | 0.5 · Binding occupancy θ |
| 68 | 0.8 · Binding occupancy θ |
| 1.8214285714285714 | 0.5000000000000001 · Assigned normalized response r |
| 17 | 0.903225806451613 · Assigned normalized response r |
| 68 | 0.973913043478261 · Assigned normalized response r |
Original independent recognition/readout model with K_d=17.0 nmol L⁻¹ and a=0.120. Circles show occupancy θ, squares show separately normalized response r at the same three free ligand concentrations. The dashed curve samples only r=(1+a)θ/(a+θ). At L=K_d, occupancy is one-half while response is about 0.903; response is one-half at L≈1.82143 nmol L⁻¹. This is a stipulated response function, not measured efficacy or a clinical effect.
A signal can alter a finite downstream pool
Suppose a downstream constituent can occupy an inactive and an active state. Activation and deactivation rates determine how its amount changes. A steady active pool can have continuing turnover in both directions, just as a stable metabolite amount can coexist with flux.
Time matters: an equilibrium occupancy model and a changing downstream pool are different descriptions. A response after a short interval need not equal its limiting response. The pool inventory bounds a fraction even when the receptor-mediated signal is amplified.
A cellular response needs its own evidence
Receptor abundance, localization, access to ligand and downstream partners help determine the observed response. A measurement made in one engineered system can answer a well-defined question without settling how every cell or organism responds.
Report the actual endpoint, concentration basis and timing. A useful explanation connects recognition to measured output while keeping the assumptions of each model visible. The original models here contain no measured receptor potency or prediction of a therapeutic effect.
Worked examples
Keep bound ligand in the total inventory
Use receptor 2.40, K_d 11.0 and free ligand 33.0 nmol L⁻¹.
- θ=33/(11+33)=0.750.
- Bound receptor=2.40×0.750=1.80 nmol L⁻¹.
- Corresponding local total ligand=34.8 nmol L⁻¹.
The total includes the bound inventory.
Normalize exclusive receptor states
Use L/K_d,L=1 and C/K_d,C=2.
- Weights empty/L/C are 1/1/2.
- Fractions are 0.250/0.250/0.500.
- Without the competitor, L fraction would be 0.500.
The model uses maintained free concentrations and one mutually exclusive site.
Calculate finite active-state persistence
Use pool 72.0 μmol L⁻¹, θ 0.300, k_act 1.20/k_deact 0.160 min⁻¹.
- λ=0.520 min⁻¹ and X_ss=49.8461538 μmol L⁻¹.
- At 4.00 min active X=43.6188633 μmol L⁻¹.
- Inactive X=28.3811367 μmol L⁻¹ preserves the total 72.0.
A steady limit and a finite-time response are different quantities.
Invert the specified readout instead of substituting K_d
Use K_d 17.0 nmol L⁻¹ and a 0.120.
- At L 17.0, θ=0.500 but r=0.903225806.
- Half response requires θ=a/(1+2a)=0.0967741935.
- EC₅₀=K_d a/(1+a)=1.82142857 nmol L⁻¹.
The response half-point and binding half-point differ in this assigned model.
Try it yourself
Supply closed total ligand 4.10 nmol L⁻¹ at the same receptor 2.40/K_d 11.0. Find bound/free ligand and compare total-as-free substitution.
Show the answer and reasoning
Bound 0.581615827/free 3.51838417 nmol L⁻¹; naive bound 0.651655629 nmol L⁻¹.
Solve 11x=(2.40−x)(4.10−x) and keep both free inventories nonnegative.
Change only maintained free competitor from 42.0 to 7.00 nmol L⁻¹ in the competition model. Find all three receptor fractions.
Show the answer and reasoning
Empty 3/7, L-bound 3/7, competitor-bound 1/7.
Normalize weights 1/1/⅓; no downstream response has been assigned by this calculation.
At 4.00 min set the state model’s receptor occupancy to zero. Find active/inactive concentrations two minutes later.
Show the answer and reasoning
Active 31.6737956/inactive 40.3262044 μmol L⁻¹.
Activation vanishes while existing active material decays at 0.160 min⁻¹; the total pool remains 72.0.
Increase only a from 0.120 to 1.20 in the normalized response model. Find EC₅₀ and the binding K_d.
Show the answer and reasoning
EC₅₀=9.27272727 nmol L⁻¹; K_d remains 17.0 nmol L⁻¹.
The changed response function uses K_d a/(1+a), while the independently stipulated binding relation is unchanged.
What to carry forward
- Free ligand and total ligand can differ when binding depletes a finite pool.
- Competitors share the same stated receptor inventory.
- Binding occupancy and a downstream response are different quantities.
- A response midpoint need not equal the binding dissociation constant.
References
Teaching resources and reference material supporting this lesson’s explanations and examples.
- General Principles of Cell CommunicationBruce Alberts; Alexander Johnson; Julian Lewis; Martin Raff; Keith Roberts; Peter Walter; original Garland Science textbook, not NCBI authorshipSource
- Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptorsP.G. Strange; School of Pharmacy, University of Reading UKSource
- Pharmacological Characterization of GPCR Agonists, Antagonists, Allosteric Modulators and Biased Ligands from HTS Hits to Lead OptimizationChi Shing Sum; Brian J. Murphy; Zhuyin Li; Tao Wang; Litao Zhang; Mary Ellen Cvijic; Bristol-Myers Squibb New Jersey USA; Assay Guidance Manual publicationSource · PDF
- A Guide to Simple and Informative Binding AssaysThomas D. Pollard; Yale University USASource